We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
-14.15%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$69.6B
AUM Growth
-$16.5B
(-19%)
Cap. Flow
-$3.3B
Cap. Flow
% of AUM
-4.75%
Top 10 Holdings %
Top 10 Hldgs %
17.71%
Holding
779
New
83
Increased
294
Reduced
313
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$753M |
| 2 |
Marathon Petroleum
MPC
|
+$374M |
| 3 |
Target
TGT
|
+$361M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$299M |
| 5 |
Huntington Bancshares
HBAN
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANDV
Andeavor
ANDV
|
+$1.05B |
| 2 |
Merck
MRK
|
+$702M |
| 3 |
Bank of America
BAC
|
+$542M |
| 4 |
Oracle
ORCL
|
+$528M |
| 5 |
Steel Dynamics
STLD
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.74% |
| 2 | Healthcare | 14.95% |
| 3 | Industrials | 13.38% |
| 4 | Technology | 12.24% |
| 5 | Energy | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FBM
576
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $1.68M | ﹤0.01% |
202,189
+3,417
| +2% | +$33.9K |
|
577
Sensata Technologies
ST
$5.97B
| $1.67M | ﹤0.01% |
+37,293
| New | +$1.69M |
|
|
BRSL
578
Brightstar Lottery PLC
BRSL
$2.11B
| $1.67M | ﹤0.01% |
114,194
-196,102
| -63% | -$3.24M |
|
|
MPT
579
Medical Properties Trust
MPT
$2.44B
| $1.66M | ﹤0.01% |
+102,908
| New | +$1.63M |
|
580
Magnite
MGNI
$3.4B
| $1.65M | ﹤0.01% |
442,767
-103,068
| -19% | -$394K |
|
581
Stagwell
STGW
$2.14B
| $1.59M | ﹤0.01% |
610,360
-543,980
| -47% | -$1.55M |
|
582
TETRA Technologies
TTI
$1.01B
| $1.59M | ﹤0.01% |
943,760
+4,539
| +0.5% | +$12.6K |
|
583
Astec Industries
ASTE
$999M
| $1.58M | ﹤0.01% |
52,500
+19,500
| +59% | +$739K |
|
|
SRGA
584
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $1.58M | ﹤0.01% |
14,252
+4,562
| +47% | +$594K |
|
585
AT&T
T
$178B
| $1.58M | ﹤0.01% |
73,229
+5,820
| +9% | +$135K |
|
586
LyondellBasell Industries
LYB
$20.6B
| $1.56M | ﹤0.01% |
+18,786
| New | +$1.72M |
|
|
MIXT
587
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $1.55M | ﹤0.01% |
+99,000
| New | +$1.58M |
|
588
Akebia Therapeutics
AKBA
$243M
| $1.54M | ﹤0.01% |
+279,378
| New | +$2.19M |
|
|
CASA
589
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $1.54M | ﹤0.01% |
117,129
+1,071
| +0.9% | +$15.4K |
|
590
Hexcel
HXL
$7.17B
| $1.53M | ﹤0.01% |
26,644
-7,912
| -23% | -$477K |
|
591
Korn Ferry
KFY
$4.43B
| $1.53M | ﹤0.01% |
38,629
-13,822
| -26% | -$622K |
|
|
EFII
592
DELISTED
Electronics for Imaging
EFII
| $1.53M | ﹤0.01% |
61,589
-24,837
| -29% | -$716K |
|
593
Forward Air
FWRD
$574M
| $1.52M | ﹤0.01% |
27,744
-13,607
| -33% | -$836K |
|
594
Natural Gas Services Group
NGS
$447M
| $1.52M | ﹤0.01% |
92,200
-19,009
| -17% | -$364K |
|
595
Bristol-Myers Squibb
BMY
$136B
| $1.51M | ﹤0.01% |
29,100
| – | – |
|
596
SouthState Bank Corp
SSB
$10.3B
| $1.51M | ﹤0.01% |
25,212
+483
| +2% | +$33.5K |
|
|
CVA
597
DELISTED
Covanta Holding Corporation
CVA
| $1.5M | ﹤0.01% |
112,000
-75,270
| -40% | -$1.16M |
|
|
MNTX
598
DELISTED
Manitex International, Inc.
MNTX
| $1.5M | ﹤0.01% |
264,083
-55,375
| -17% | -$429K |
|
599
Tidewater
TDW
$4.61B
| $1.49M | ﹤0.01% |
77,736
+19,437
| +33% | +$506K |
|
600
Dentsply Sirona
XRAY
$2.22B
| $1.48M | ﹤0.01% |
+39,754
| New | +$1.45M |
|
Similar funds
Boston Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Boston Partners held 779 positions worth $69.6B, down 19% from $86.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Boston Partners withdrew a net $3.3B in Q4 2018, closing 76 positions and reducing 313 holdings. Its most notable exit was Andeavor, an estimated $1.05B position sold in full.
By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Boston Partners opened a new position in Procter & Gamble worth $775M.
- Boston Partners's largest Q4 2018 buy was Procter & Gamble: 8,428,522 shares worth $775M.
- Boston Partners added most to Marathon Petroleum in Q4 2018, an estimated $374M increase.
- Boston Partners's biggest Q4 2018 reduction was Merck, cutting an estimated $702M.
- Boston Partners fully exited Andeavor in Q4 2018, selling an estimated $1.05B.
- Boston Partners's ten largest holdings make up 18% of its $69.6B portfolio in Q4 2018.
- Boston Partners opened 83 new positions and closed 76 in Q4 2018.
- Boston Partners's portfolio value fell 19% quarter-over-quarter to $69.6B.
Based on Boston Partners's 13F filing for Q4 2018, filed 7 Feb 2019.